脑电生物反馈仪治疗伴有睡眠障碍的抑郁症疗效分析

摘要

Objective:To investigate the efficacy of EEG bio-feedback instrument in treating depressive patients with sleep disorders.Methods:Eighty-four patients with depression accompanied by sleep disorders were selected and randomly divided into two groups,the experimental and control groups (n=42 respectively).The cases in the control group were treated with routine drug therapy and psychotherapy;while those in the experimental group were administrated with routine drug therapy,psychotherapy and EEG bio-feedback therapy.The Hamilton Depression Scale (HAMD) and the Pittsburgh Sleep Quality Index (PSQI) were used to evaluate all the patients before,3 and 6 weeks after treatment,respectively.Results:There were no statistical differences in the HAMD and PSQI scores between the two groups before treatment (P＞0.05).The HAMD and PSQI scores in the experimental group were statistically lower than those in the control group at 3 and 6 weeks after treatment (P＜0.05).Conclusion:EEG bio-feedback is an effective to treat patients with depression accompanied by sleep disorders.%目的:观察生物反馈仪对伴有睡眠障碍症状的抑郁症患者的疗效.方法:伴有睡眠障碍的抑郁症患者84例,随机分为观察组和对照组,各42例.对照组患者给予常规的药物及心理治疗,观察组患者在此基础上增加生物反馈仪治疗.于对治疗前,治疗后3、6周采用汉密尔顿抑郁量表(HAMD)和匹兹堡睡眠质量指数量表(PSQI)对2组进行测量并分析.结果:治疗前2组HAMD评分和PSQI评分差异无统计学意义(P＞0.05);治疗3、6周后,观察组的HAMD评分和PSQI评分均低于对照组(P＜0.05).结论:药物联合脑电生物反馈仪治疗伴有睡眠障碍的抑郁症疗效优于单纯药物治疗.